Wellington Management Group LLP Apellis Pharmaceuticals, Inc. Transaction History
Wellington Management Group LLP
- $529 Billion
- Q2 2025
A detailed history of Wellington Management Group LLP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 8,976,962 shares of APLS stock, worth $215 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,976,962
Previous 12,303,252
27.04%
Holding current value
$215 Million
Previous $269 Million
42.25%
% of portfolio
0.03%
Previous 0.05%
Shares
23 transactions
Others Institutions Holding APLS
# of Institutions
295Shares Held
132MCall Options Held
2.95MPut Options Held
621K-
Avoro Capital Advisors LLC New York, NY12.2MShares$292 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$284 Million17.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$243 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$233 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT7MShares$167 Million4.3% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.63B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...